From Prescription to Patient: Navigating Barriers to HCV Treatment Initiation

Publish date:
October 19, 2016
Review date:
June 18, 2021
AETC Source
Southeast AETC
Link to File & Online Module

Objectives

  • Describe the financial impact of HCV treatment
  • Identify current restrictions to HCV treatment common among third party payers
  • Illustrate successful navigation through the prior authorization and appeal process
  • Review criteria and options for patient assistance programs (PAP)

Speaker

Autumn Bagwell PharmD BCPS

Browse more